The latest closing stock price for Protagonist Therapeutics as of January 21, 2025 is 38.10.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,256 today, roughly 2 times their original investment - a 15.90% compound annual growth rate over 8 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.89, which is 28.3% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 24.21, which is 36.5% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 36.02.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,256 today, roughly 2 times their original investment - a 15.90% compound annual growth rate over 8 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.89, which is 28.3% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 24.21, which is 36.5% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 36.02.